Eli Lilly and Co. says it will settle about 18,000 lawsuits alleging the drugmaker did not adequately warn patients that its anti-psychotic medication Zyprexa carries a heightened risk of diabetes. A Lilly spokeswoman said the claims were less viable than 8,000 cases the company settled for about $700 million in 2005, due to a Zyprexa labeling change addressing diabetes risks. She said Lilly will go to trial to resolve 1,200 remaining cases, which she said are not being settled for "various reasons."
January 05, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Eli Lilly and Co. has said it will settle about 18,000 additional lawsuits alleging the drugmaker did not adequately warn patients that its anti-psychotic medication Zyprexa carries a heightened risk of diabetes.
Lilly did not disclose the amount of the settlement but said in a statement it would take a fourth-quarter settlement charge that’s not expected to exceed $500 million.
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Role TitleAssociate General Counsel, Global EmploymentGrade F13Reporting ToSenior Legal Counsel, Global EmploymentProgram/Tool/ Department/U...
Ryan & Conlon, LLP, is a boutique firm specializing in insurance defense. We are a small eclectic practice with a busy and fast paced en...
INTELLECTUAL PROPERTY PROSECUTION PARALEGAL - NEW JERSEY OR NEW YORK OFFICESProminent mid-Atlantic law firm with multiple regional office lo...
